GSK

Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
Next stage in GSK’s Zantac defense gets underway today
Pharmaphorum
Mon, 01/22/24 - 11:13 am
GSK
Zantac
legal
cancer
GSK raises $1.24 bln from latest Haleon stake sale
Reuters
Wed, 01/17/24 - 09:22 am
GSK
consumer health
Haleon
spinoffs
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Curevo’s shingles vaccine equals GSK’s Shingrix in phase 2 head-to-head
Fierce Biotech
Tue, 01/9/24 - 09:47 am
Curevo Vaccine
GSK
shingles
vaccines
Shingrix
GSK amends commercial deal with Scynexis as antifungal recall drags into 2024
Fierce Pharma
Wed, 01/3/24 - 04:57 pm
GSK
Scynexis
Brexafemme
antifungals
GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
GSK
Hansoh Pharmaceutical
antibody-drug conjugate
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
GSK
Zejula
Jemperli
endometrial cancer
clinical trials
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
Reuters
Thu, 11/30/23 - 11:12 pm
GSK
RSV
vaccines
Emma Walmsley
Pharma CEOs
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Merck
GSK
chronic cough
Bellus Health
gefapixant
Camlipixant
GSK cancer drug Blenrep gets surprise trial win
BioPharma Dive
Tue, 11/28/23 - 10:19 am
GSK
Blenrep
clinical trials
Multiple Myeloma
GSK says new inhaler will help slash its carbon footprint
Pharmaphorum
Tue, 11/21/23 - 10:39 pm
GSK
inhalers
carbon emisssions
sustainability
Hepatitis B drug developers chart slow progress forward, just like hep C before it
Fierce Biotech
Tue, 11/14/23 - 09:35 am
hepatitis B
hepatitis C
drug development
Assembly Biosciences
GSK
Aligos Therapeutics
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive
Wed, 11/1/23 - 11:19 am
GSK
Pfizer
vaccines
RSV
Arexvy
Abrysvo
GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales
BioSpace
Wed, 11/1/23 - 11:13 am
GSK
earnings
Arexvy
Shingrix
GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy
Reuters
Tue, 10/31/23 - 10:18 am
GSK
JNJ
hepatitis B
JNJ-3989
Janssen
GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
Fierce Pharma
Mon, 10/30/23 - 10:12 am
GSK
Jemperli
endometrial cancer
clinical trials
GSK targets younger age group with RSV vaccine Arexvy
Pharmaphorum
Wed, 10/25/23 - 09:43 am
GSK
RSV
Arexvy
vaccines
Pfizer beats out GSK with FDA nod for first 5-in-1 meningitis shot
Fierce Pharma
Sun, 10/22/23 - 06:16 pm
Pfizer
GSK
vaccines
FDA
Penbraya
meningococcal disease

Pages